Nikolai I. Tankovich
Presidente presso Stemedica Cell Technologies, Inc.
Profilo
Nikolai I.
Tankovich is currently the Director at Biopharma Scientific, Inc. and the President, Director & Chief Medical Officer at Stemedica Cell Technologies, Inc. He holds a doctorate degree from Moscow State University Lomonosov and Semashco Medical University, and a graduate degree from Moscow University.
Posizioni attive di Nikolai I. Tankovich
| Società | Posizione | Inizio |
|---|---|---|
Biopharma Scientific, Inc.
 Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Direttore/Membro del Consiglio | - |
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Presidente | - |
Formazione di Nikolai I. Tankovich
| Moscow State University Lomonosov | Doctorate Degree |
| Moscow University | Graduate Degree |
| Semashco Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Biopharma Scientific, Inc.
Biopharma Scientific, Inc. Pharmaceuticals: MajorHealth Technology Biopharma Scientific, Inc. develops and manufactures pharmaceuticals. It provides new frontier of nutrition through nanotechnology delivery systems, innovations in bio-active extraction processes and advanced formulation methodologies. The company was founded by John H. Maher and Bruce L. Howe in 2004 and is headquartered in San Diego, CA | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Nikolai I. Tankovich
